Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study
- Fatukasi, T.V.
- Edmonds, A.
- Gustafson, D.R.
- Cole, S.R.
- Edwards, J.K.
- Bolivar, H.
- Cohen, M.
- Fischl, M.A.
- Gange, S.
- Konkle-Parker, D.
- Moran, C.A.
- Plankey, M.
- Sharma, A.
- Tien, P.C.
- Adimora, A.A.
DOIAbstract
A previous cross-sectional analysis of 2028 women in the Women’s Interagency HIV Study (WIHS), who were on average 39 years old, found a frailty prevalence of 17% and 10% in women with or at risk for HIV, respectively [1]. To our knowledge, the only two longitudinal studies of frailty among people with HIV were conducted in the Multicenter AIDS Cohort Study (MACS), which includes only men [2,3]. Data on the distribution of frailty components are limited, and have not been reported for HIV-seropositive people in the United State
Add to ORKG